1. Development or worsening of sarcoidosis associated with IL‐17 blockade for psoriasis. (19th May 2020) Authors: Hornick, N.; Wang, A.; Lim, Y.; Gehlhausen, J.; Siegel, J.; Wang, J.; Foss, F.; Lim, I.; Zubek, A.; Milstone, L.; Galan, A.; King, B.; Damsky, W. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 10(2020) Page Start: e583 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Interleukin‐17 blockade downregulates NOD2 in skin and may promote paradoxical sarcoidosis. (6th May 2020) Authors: Wang, A.; Hornick, N.; Lim, Y.; Gehlhausen, J.; Siegel, J.; Wang, J.; Foss, F.; Lim, I.; Zubek, A.; Milstone, L.; Galan, A.; King, B.; Damsky, W. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 9(2020) Page Start: e497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗